PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Deficiency Vitamin D 8 Disease Disease Inflammation 252,734 1 0.00 -0.94 0.12 0.57
Deficiency Vitamin D 8 Disease Disease Muscle Weakness 9,178 1 0.00 -0.94 0.12 0.64
Deficiency Vitamin D 8 Disease Disease Cholesterol 182,390 1 0.00 -0.94 0.12 0.57
Deficiency Vitamin D 8 Disease Disease Arthritis 128,324 1 0.00 -0.94 0.12 0.58
Deficiency Vitamin D 8 Disease Disease Osteoporosis 46,215 1 0.00 -0.94 0.12 0.60
DNAJB1 44 Target Disease Liver Disease 49,817 1 0.00 -0.99 0.02 0.58
DNAJB1 44 Target Target BDNF 11,163 1 0.00 -0.99 0.02 0.61
Acute Promyelocytic Leukemia 4,780 Disease Disease Seizures 66,465 1 0.00 -1.00 0.00 0.47
DNAJB1 44 Target Disease Leukemia 162,805 1 0.00 -0.99 0.02 0.55
DNAJB1 44 Target Target ERK2 3,287 1 0.00 -0.99 0.02 0.64
DNAJB1 44 Target Disease Schizophrenia 77,034 1 0.00 -0.99 0.02 0.57
DNAJB1 44 Target Disease Infection 766,637 1 0.00 -0.99 0.02 0.52
DNAJB1 44 Target Disease Diarrhea 51,986 1 0.00 -0.99 0.02 0.57
Ck-beta-11 4 Target Target Exodus-3 8 1 0.18 -0.81 0.25 0.89
Ck-beta-11 4 Target Target CD34 24,598 1 0.00 -0.87 0.25 0.63
Ck-beta-11 4 Target Disease Breast Cancer 173,695 1 0.00 -0.87 0.25 0.59
Ck-beta-11 4 Target Target Exodus-2 27 1 0.10 -0.85 0.25 0.84
Arixtra (Fondaparinux Sodium)- FDA 16 Drug Disease Pain 409,851 1 0.00 -0.97 0.06 0.55
Arixtra (Fondaparinux Sodium)- FDA 16 Drug Disease Renal Failure 73,993 1 0.00 -0.97 0.06 0.58
DNAJB1 44 Target Target Cox-2 21,583 1 0.00 -0.99 0.02 0.59
Acute Promyelocytic Leukemia 4,780 Disease Target Phospholipase A2 13,400 1 0.00 -1.00 0.00 0.51
Acute Promyelocytic Leukemia 4,780 Disease Target BMP-6 386 1 0.00 -1.00 0.00 0.60
Acute Promyelocytic Leukemia 4,780 Disease Disease Coma 24,208 1 0.00 -1.00 0.00 0.50
EPHA4 357 Target Target CCL2 3,560 1 0.00 -1.00 0.00 0.61
EPHA4 357 Target Disease Arthritis 128,324 1 0.00 -1.00 0.00 0.52
EPHA4 357 Target Target ERK1 18,374 1 0.00 -1.00 0.00 0.56
EPHA4 357 Target Disease Lung Carcinoma 13,423 1 0.00 -1.00 0.00 0.57
EPHA4 357 Target Disease Williams Syndrome 1,261 1 0.00 -1.00 0.00 0.64
EPHA4 357 Target Disease Stroke 146,992 1 0.00 -1.00 0.00 0.51
EPHA4 357 Target Disease Bladder Cancer 21,509 1 0.00 -1.00 0.00 0.56
EPHA4 357 Target Disease Schizophrenia 77,034 1 0.00 -1.00 0.00 0.53
EPHA4 357 Target Disease Glaucoma 41,465 1 0.00 -1.00 0.00 0.54
EPHA4 357 Target Disease Inflammatory Bowel Disease 24,375 1 0.00 -1.00 0.00 0.55
EPHA4 357 Target Target APOE 12,771 1 0.00 -1.00 0.00 0.57
EPHA4 357 Target Disease Hyperglycemia 28,168 1 0.00 -1.00 0.00 0.55
Histamine H1 Receptor 1,170 Target Disease Infertility 35,448 1 0.00 -1.00 0.00 0.52
Histamine H1 Receptor 1,170 Target Target CXCL2 750 1 0.00 -1.00 0.00 0.63
Histamine H1 Receptor 1,170 Target Disease Heart Disease 118,291 1 0.00 -1.00 0.00 0.49
Histamine H1 Receptor 1,170 Target Disease Liver Disease 49,817 1 0.00 -1.00 0.00 0.51
Histamine H1 Receptor 1,170 Target Target CXCL10 2,386 1 0.00 -1.00 0.00 0.59
Histamine H1 Receptor 1,170 Target Disease Ulcers 45,142 1 0.00 -1.00 0.00 0.51
Histamine H1 Receptor 1,170 Target Target BDNF 11,163 1 0.00 -1.00 0.00 0.55
Histamine H1 Receptor 1,170 Target Disease Proteinuria 28,803 1 0.00 -1.00 0.00 0.53
Histamine H1 Receptor 1,170 Target Disease Sinusitis 12,330 1 0.00 -1.00 0.00 0.55
Histamine H1 Receptor 1,170 Target Disease Breast Cancer 173,695 1 0.00 -1.00 0.00 0.48
Histamine H1 Receptor 1,170 Target Disease Glioblastoma 17,933 1 0.00 -1.00 0.00 0.54
EPHA4 357 Target Target BMP-7 1,112 1 0.00 -1.00 0.00 0.64
EPHA4 357 Target Disease Rheumatoid Arthritis 78,952 1 0.00 -1.00 0.00 0.53
EPHA4 357 Target Disease Hepatitis 163,842 1 0.00 -1.00 0.00 0.51
Acute Promyelocytic Leukemia 4,780 Disease Disease Drug Hypersensitivity 902 1 0.00 -1.00 0.00 0.58